Insider trades
Jon Faiz Kayyem, Director of Inhibrx Biosciences INBX, has filed 12 purchases and 1 sale on the open market. Over the past 12 months that comes to a net purchase of $500K. The latest trade was on 09/23.
Jon Faiz Kayyem
Director
- Company
- Inhibrx Biosciences INBX
- First filing
- 23/01/05
- Trades
- 48 trades
- Buys / sales
- 12 / 1
- 12-month net buying
- $500K
- Last trade
- 09/23
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 09/23 | 09/23 | 5,000 sh | $100.00 | $500,000 | +1.2% | |
INBX | Open-market buy | 24/11/19–24/11/20 | 24/11/22 | 107,186 sh4 trades | $14.22avg. | $1,523,756.78 | No record |
INBX | Open-market buy | 24/06/05 | 24/06/07 | 57,549 sh2 trades | $17.32avg. | $997,024.17 | +5.3% |
INBX | Open-market buy | 24/05/31–24/06/04 | 24/06/04 | 286,786 sh5 trades | $17.18avg. | $4,927,579.86 | +35.6% |
| Open-market sale | 23/01/23 | 23/01/23 | 9,500 sh | $25.26 | $239,970 | −0.3% |